|3Jul 29, 10:56 AM ET

RxSight I, LLC 3

3 · RxSight, Inc. · Filed Jul 29, 2021

Insider Transaction Report

Form 3
Period: 2021-07-29
Holdings
  • Series H Preferred Stock

    Common Stock (2,016,778 underlying)
Footnotes (1)
  • [F1]All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer will automatically be converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock.

Documents

1 file
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION